Proton Therapy for Prostate Cancer Patients Offers Long-Term Patient Survival with Optimal Quality of Life
|
By MedImaging International staff writers Posted on 26 Feb 2014 |
|
Image: Patient preparing to undergo proton therapy (Photo courtesy of the University of Florida Proton Therapy Institute).
Five years after having proton therapy for the treatment of early- and intermediate-risk prostate cancer, 99% of men are cancer-free and with excellent quality of life, according to new findings. Three-quarters of those patients with high-risk prostate cancer are also disease-free.
The University of Florida (UF) Proton Therapy Institute (Jacksonville, USA) study, published in the March 1, 2014, issue of the International Journal of Radiation Oncology Biology Physics, adds to the body of evidence pointing to an important role for proton therapy in the effective treatment of prostate cancer, according to Nancy P. Mendenhall, MD, lead author and medical director of the UF Proton Therapy Institute.
“These proton therapy results compare very favorably with IMRT [intensity-modulated radiation therapy] results, particularly for intermediate risk-disease, where disease control rates of 70%–85% are typical,” said Dr. Mendenhall, the associate chair of the UF College of Medicine department of radiation oncology. IMRT is a type of radiation that uses photons, or X-rays, to deliver radiation. Proton therapy utilizes protons, particles of an atom, to deliver radiation.
The study monitored 211 patients who participated in prospective Institutional Review-Board approved trials. In each track, patients were administered proton therapy over an eight-week period, a shorter interval than typical with IMRT, which may last nine to nine-and-a-half weeks. Researchers used standardized data-collecting techniques for both physician-reported and patient-reported outcomes.
The findings revealed cancer-free survival rates at five years for low-, intermediate-, and high-risk patients are 99%, 99%, and 76%, respectively, whereas overall survival rates are 93%, 88%, and 90%. Furthermore, the serious gastrointestinal and urologic complication rate is low, at 1.4% and 5.3%, respectively, for all patients. Patients also reported good outcomes in relation to both urologic and bowel functions.
Related Links:
University of Florida Proton Therapy Institute
The University of Florida (UF) Proton Therapy Institute (Jacksonville, USA) study, published in the March 1, 2014, issue of the International Journal of Radiation Oncology Biology Physics, adds to the body of evidence pointing to an important role for proton therapy in the effective treatment of prostate cancer, according to Nancy P. Mendenhall, MD, lead author and medical director of the UF Proton Therapy Institute.
“These proton therapy results compare very favorably with IMRT [intensity-modulated radiation therapy] results, particularly for intermediate risk-disease, where disease control rates of 70%–85% are typical,” said Dr. Mendenhall, the associate chair of the UF College of Medicine department of radiation oncology. IMRT is a type of radiation that uses photons, or X-rays, to deliver radiation. Proton therapy utilizes protons, particles of an atom, to deliver radiation.
The study monitored 211 patients who participated in prospective Institutional Review-Board approved trials. In each track, patients were administered proton therapy over an eight-week period, a shorter interval than typical with IMRT, which may last nine to nine-and-a-half weeks. Researchers used standardized data-collecting techniques for both physician-reported and patient-reported outcomes.
The findings revealed cancer-free survival rates at five years for low-, intermediate-, and high-risk patients are 99%, 99%, and 76%, respectively, whereas overall survival rates are 93%, 88%, and 90%. Furthermore, the serious gastrointestinal and urologic complication rate is low, at 1.4% and 5.3%, respectively, for all patients. Patients also reported good outcomes in relation to both urologic and bowel functions.
Related Links:
University of Florida Proton Therapy Institute
Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
New
X-Ray Detector
FDR-D-EVO III
Thyroid Shield
Standard Thyroid Shield
Silver Member
Mobile X-Ray Barrier
Lead Acrylic Mobile X-Ray Barriers
Latest Nuclear Medicine News
- New Imaging Technique Monitors Inflammation Disorders without Radiation Exposure
- New SPECT/CT Technique Could Change Imaging Practices and Increase Patient Access
- New Radiotheranostic System Detects and Treats Ovarian Cancer Noninvasively
- AI System Automatically and Reliably Detects Cardiac Amyloidosis Using Scintigraphy Imaging
- Early 30-Minute Dynamic FDG-PET Acquisition Could Halve Lung Scan Times
- New Method for Triggering and Imaging Seizures to Help Guide Epilepsy Surgery
- Radioguided Surgery Accurately Detects and Removes Metastatic Lymph Nodes in Prostate Cancer Patients
- New PET Tracer Detects Inflammatory Arthritis Before Symptoms Appear
- Novel PET Tracer Enhances Lesion Detection in Medullary Thyroid Cancer
- Targeted Therapy Delivers Radiation Directly To Cells in Hard-To-Treat Cancers
- New PET Tracer Noninvasively Identifies Cancer Gene Mutation for More Precise Diagnosis
- Algorithm Predicts Prostate Cancer Recurrence in Patients Treated by Radiation Therapy
- Novel PET Imaging Tracer Noninvasively Identifies Cancer Gene Mutation for More Precise Diagnosis
- Ultrafast Laser Technology to Improve Cancer Treatment
- Low-Dose Radiation Therapy Demonstrates Potential for Treatment of Heart Failure
- New PET Radiotracer Aids Early, Noninvasive Detection of Inflammatory Bowel Disease
Channels
Radiography
view channel
Novel Breast Imaging System Proves As Effective As Mammography
Breast cancer remains the most frequently diagnosed cancer among women. It is projected that one in eight women will be diagnosed with breast cancer during her lifetime, and one in 42 women who turn 50... Read more
AI Assistance Improves Breast-Cancer Screening by Reducing False Positives
Radiologists typically detect one case of cancer for every 200 mammograms reviewed. However, these evaluations often result in false positives, leading to unnecessary patient recalls for additional testing,... Read more
MRI
view channel
World's First Sensor Detects Errors in MRI Scans Using Laser Light and Gas
MRI scanners are daily tools for doctors and healthcare professionals, providing unparalleled 3D imaging of the brain, vital organs, and soft tissues, far surpassing other imaging technologies in quality.... Read more
Diamond Dust Could Offer New Contrast Agent Option for Future MRI Scans
Gadolinium, a heavy metal used for over three decades as a contrast agent in medical imaging, enhances the clarity of MRI scans by highlighting affected areas. Despite its utility, gadolinium not only... Read more.jpg "Image: The emerging role of MRI alongside PSA testing is redefining prostate cancer diagnostics (Photo courtesy of 123RF)")
Combining MRI with PSA Testing Improves Clinical Outcomes for Prostate Cancer Patients
Prostate cancer is a leading health concern globally, consistently being one of the most common types of cancer among men and a major cause of cancer-related deaths. In the United States, it is the most... Read more
Ultrasound
view channel
Largest Model Trained On Echocardiography Images Assesses Heart Structure and Function
Foundation models represent an exciting frontier in generative artificial intelligence (AI), yet many lack the specialized medical data needed to make them applicable in healthcare settings.... Read more.jpg "Image: The Sonic Lumen Tomography (SLT) intravascular ultrasound system has received FDA 510(k) clearance (Photo courtesy of Provisio Medical)")
Groundbreaking Technology Enables Precise, Automatic Measurement of Peripheral Blood Vessels
The current standard of care of using angiographic information is often inadequate for accurately assessing vessel size in the estimated 20 million people in the U.S. who suffer from peripheral vascular disease.... Read more
Deep Learning Advances Super-Resolution Ultrasound Imaging
Ultrasound localization microscopy (ULM) is an advanced imaging technique that offers high-resolution visualization of microvascular structures. It employs microbubbles, FDA-approved contrast agents, injected... Read more
Novel Ultrasound-Launched Targeted Nanoparticle Eliminates Biofilm and Bacterial Infection
Biofilms, formed by bacteria aggregating into dense communities for protection against harsh environmental conditions, are a significant contributor to various infectious diseases. Biofilms frequently... Read moreGeneral/Advanced Imaging
view channel
PET Scans Reveal Hidden Inflammation in Multiple Sclerosis Patients
A key challenge for clinicians treating patients with multiple sclerosis (MS) is that after a certain amount of time, they continue to worsen even though their MRIs show no change. A new study has now... Read more
Artificial Intelligence Evaluates Cardiovascular Risk from CT Scans
Chest computed tomography (CT) is a common diagnostic tool, with approximately 15 million scans conducted each year in the United States, though many are underutilized or not fully explored.... Read more
New AI Method Captures Uncertainty in Medical Images
In the field of biomedicine, segmentation is the process of annotating pixels from an important structure in medical images, such as organs or cells. Artificial Intelligence (AI) models are utilized to... Read more.jpg "Image: CT coronary angiography for diagnosing coronary artery disease offers advantages over other diagnostic tests (Photo courtesy of 123RF)")
CT Coronary Angiography Reduces Need for Invasive Tests to Diagnose Coronary Artery Disease
Coronary artery disease (CAD), one of the leading causes of death worldwide, involves the narrowing of coronary arteries due to atherosclerosis, resulting in insufficient blood flow to the heart muscle.... Read moreImaging IT
view channel
New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible
Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Global AI in Medical Diagnostics Market to Be Driven by Demand for Image Recognition in Radiology
The global artificial intelligence (AI) in medical diagnostics market is expanding with early disease detection being one of its key applications and image recognition becoming a compelling consumer proposition... Read more
Industry News
view channel
Bayer and Google Partner on New AI Product for Radiologists
Medical imaging data comprises around 90% of all healthcare data, and it is a highly complex and rich clinical data modality and serves as a vital tool for diagnosing patients. Each year, billions of medical... Read more
